A detailed history of Claret Asset Management Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Claret Asset Management Corp holds 2,298 shares of BSX stock, worth $223,641. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,298
Previous 2,687 14.48%
Holding current value
$223,641
Previous $271,000 8.86%
% of portfolio
0.03%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

SELL
$89.7 - $107.41 $34,893 - $41,782
-389 Reduced 14.48%
2,298 $247,000
Q1 2025

May 13, 2025

BUY
$89.38 - $106.18 $178 - $212
2 Added 0.07%
2,687 $271,000
Q4 2024

Feb 13, 2025

BUY
$83.62 - $91.5 $1,421 - $1,555
17 Added 0.64%
2,685 $240,000
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $948 - $1,092
13 Added 0.49%
2,668 $224,000
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $178,761 - $206,320
2,655 New
2,655 $204,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $139B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Claret Asset Management Corp Portfolio

Follow Claret Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.